Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK’s NICE Slashes HTA Appraisal Time For Ngenla & Ofev Using New Approach

Executive Summary

Ngenla and Ofev are the first two drugs to be evaluated using the health technology appraisal institute’s new proportionate approach – they were both appraised much faster than usual.

You may also be interested in...



England’s NICE Formalizes Faster Approach To Appraisals

NICE, the health technology appraisal body for England and Wales, has published the first update to its health technology evaluations manual setting out two of the pathways that form part of its new proportionate approach to assessments.

England’s NICE Consults On Health Technology Evaluations Guide Incorporating Proportionate Approach

NICE, the health technology appraisal body for England and Wales, is asking for views on amendments to its health technology evaluations manual to incorporate its new proportionate approach to appraisals.

NICE Pilots Show New Streamlined Approaches To Accelerated Health Technology Assessments

NICE, the health technology appraisal body for England, has published an interim process and methods guide for its new proportionate approach to HTAs.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS147565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel